Overview Efficacy Study of Gene Therapy for The Treatment of Acute LHON Onset Within Three Months Status: Active, not recruiting Trial end date: 2020-12-30 Target enrollment: Participant gender: Summary Efficacy Study of Gene Therapy for The Treatment of Acute Leber's Hereditary Optic Neuropathy (LHON) onset within three months Phase: N/A Details Lead Sponsor: Bin Li